Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Stoke Therapeutics, Inc. is a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with ribonucleic acid (RNA)-based medicines. The Company, through its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach, is engaged in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, zorevunersen (STK-001), is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. TANGO aims to restore missing proteins by increasing or stoking protein output from healthy genes, thus compensating for the non-functioning copy of the gene. The Company is pursuing the development of STK-002 for the treatment of autosomal dominant optic atrophy (ADOA), the most common inherited optic nerve disorder. The Company’s initial focus is haploinsufficiency and diseases of the central nervous system and the eye.
Find out what a historical investment in Stoke Therapeutics would be worth today using our STOK stock calculator.
Buying STOK shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Stoke Therapeutics in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in STOK
What is the ticker symbol of Stoke Therapeutics?
The ticker symbol for Stoke Therapeutics is STOK.
How much is one share of STOK?
One share of STOK is valued at $26.81 as of 22 November 2026.
What is the market capitalisation of Stoke Therapeutics STOK?
As of 22 November 2026 Stoke Therapeutics has a market cap of $1.75B.
What is the 52-week high for Stoke Therapeutics stock?
The Stoke Therapeutics 52-week high stock price is $40.22.
What is the 52-week low for Stoke Therapeutics stock?
The Stoke Therapeutics 52-week low stock price is $22.05.
Can I buy STOK shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy STOK shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in STOK on Stake
Buy STOK from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of STOK from only US$10 with fractional shares